🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Please congratulate Song Li Song Li who is the Inaugural Director of Data Science for the #CSWG. He is a #rigorous physician-scientist, #disruptive innovator, #badass coder, and #fantastic partner. We are thrilled to have him lead our statistical group! Tufts Medical Center

After 50 episodes, surely UW Cardiology UWashington Heart Institute can get Dr. Bill Lombardi a better mic so he doesn't sound like he's under water every episode

Next Tuesday (4/23) FTC will convene an open commission meeting to vote on the final rule prohibiting noncompete clauses. We received over 26,000 public comments about this proposal. Many thanks to everyone who shared their views and experiences. ftc.gov/news-events/ne…

I recognize that studies say this is why women don’t pick cardiology but this is reflective of the limitations of using surveys How can one communicate in a survey that women don’t get told they should do it, don’t see lots of women doing it and don’t get shown how to do it …

Retaining, not just recruiting, women of color in medicine is vital | The Seattle Times This is not the fault of individuals. Systems must change meaningfully. Otherwise, this will continue to happen. Our field & our patients will suffer. seattletimes.com/opinion/retain…

My personal take to the new board based on what we know now: 👍direct response to ABIM charging high fees, perceived double dipping, lack of accountability (tone deaf), overreach (choosing wisely and other irrelevant campaigns to mission of certification), changing rules

Glad u enjoyed! just learned about OpenEvidence at #aimw24 it’s amazing- We have an episode on #AIinEducation coming in a few weeks and excited about new tools to come, but important to understand how to verify the background info

Hypertrophic Cardiomyopathy (HCM) remains a common genetic heart disease in populations throughout the world. The 2024 Guideline for the Management of Hypertrophic Cardiomyopathy was published today in Circulation. ✍🏼 Steve Ommen, MD 📷 Recommended Evaluation & Testing for HCM

2024 #cvHCM Guideline now published! New recommendations regarding cardiac myosin inhibitors, use of valsartan, exercise and testing, atrial and ventricular arrhythmia risk stratification American College of Cardiology AHA Science Heart Rhythm Society Society for Cardiovascular Magnetic Resonance jacc.org/doi/10.1016/j.…

The #SEQUOIA #HCM trial results are here - Placebo-controlled trial of #aficamten in #obstructive #HCM 3 presentations in 3 threads - follow along This is the first presentation by Martin Maron, MD sharing the primary results Follow along #CardioTwitter #HeartFailure2024

Original Article: Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy (SEQUOIA-HCM trial) nej.md/3wmDzyl Editorial: Sixty Years of Hemodynamic Pharmacology in Obstructive Hypertrophic Cardiomyopathy nej.md/4bnvcBe #HeartFailure2024 European Society of Cardiology

Well, if you are flying out of Dallas Love Field Airport today, try to avoid checking a back or get there 3-4 hours early. I’ve never seen such insanity at this airport - all of these people are waiting to check bags + dealing with unkind Southwest Airlines employees.

This episode is a great listen. There are definitely some non-intuitive helpful takeaways here.

Back in Boston after 10 years for the #HCMSummit8 Highlights so far: —the seaport/southie are so different now —Boston U Chobanian & Avedisian School of Medicine looks the same :) —flour bakery+cafe still slaps —New England falls are the best —Med school friends are the best friends

Great talk by A/Prof Jodie Ingles - is HCM genetic? Probably but it’s not always familial. The best part was the review of the data - all in under 20 mins #HCMSummit8

Fascinating work from Seema Mital at the Hospital for Sick Children. On systematic review, there was reclassification of both LP/P and VUS results. Only ~5% of the variants they found that were reclassified were reported by the commercial testing companies #HCMSummit8

I might be a noninvasive cardiologist but I’m really enjoying this #HCMSummit8 session on the invasive management of HCM. Kudos to putting together such an excellent line up!

What a treat hearing John Mandrola, MD talk about AF. For what is known, so much more is unknown.